Fisher & Paykel Healthcare Overview
- Year Founded
-
1969
- Status
-
Public
- Employees
-
7,375
- Stock Symbol
-
FPH
- Investments
-
2
- Share Price
-
$26.67
- (As of Tuesday Closing)
Fisher & Paykel Healthcare General Information
Description
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
Contact Information
Website
www.fphcare.com/inCorporate Office
- 15 Maurice Paykel Place
- East Tamaki
- Auckland, 2013
- New Zealand
Corporate Office
- 15 Maurice Paykel Place
- East Tamaki
- Auckland, 2013
- New Zealand
Fisher & Paykel Healthcare Stock Performance
As of 17-Nov-2026, Fisher & Paykel Healthcare’s stock price is $26.67. Its current market cap is $15.7B with 588M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $26.67 | $26.85 | $18.75 - $28.27 | $15.7B | 588M | 520K | $0.47 |
Fisher & Paykel Healthcare Financials Summary
As of 31-Mar-2026, Fisher & Paykel Healthcare has a trailing 12-month revenue of $1.35B.
|
In Thousands, USD |
TTM 31-Mar-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 12,464,541 | 12,464,541 | 11,186,644 | 9,122,175 |
| Revenue | 1,354,536 | 1,354,536 | 757,516 | 1,070,817 |
| EBITDA | 464,852 | 464,852 | 384,586 | 222,252 |
| Net Income | 274,909 | 274,909 | 223,178 | 80,764 |
| Total Assets | 1,631,113 | 1,631,113 | 1,455,388 | 1,360,803 |
| Total Debt | 83,511 | 83,511 | 87,467 | 112,779 |
Fisher & Paykel Healthcare Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Fisher & Paykel Healthcare Comparisons
Industry
Financing
Details
Fisher & Paykel Healthcare Competitors (32)
One of Fisher & Paykel Healthcare’s 32 competitors is LivaNova, a Formerly VC-backed company based in London, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| LivaNova | Formerly VC-backed | London, United Kingdom | ||||
| Inspire Medical Systems | Formerly VC-backed | Golden Valley, MN | ||||
| Ottobock | Formerly PE-Backed | Duderstadt, Germany | ||||
| Wellell | Venture Capital-Backed | New Taipei, Taiwan | ||||
| Inogen | Formerly VC-backed | Beverly, MA |
Fisher & Paykel Healthcare Patents
Fisher & Paykel Healthcare Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2026908584-A0 | Gas path connector | Pending | 14-Oct-2026 | ||
| AU-2026904451-A0 | Under-mattress sensor for physiological parameters | Pending | 08-May-2026 | ||
| CA-245655-S | Nasal cannula assembly | Active | 16-May-2025 | ||
| CA-253789-S | Nasal cannula assembly | Active | 16-May-2025 | ||
| CA-253790-S | Nasal cannula assembly | Active | 16-May-2025 |
Fisher & Paykel Healthcare Signals
Fisher & Paykel Healthcare Investments & Acquisitions (2)
Fisher & Paykel Healthcare’s most recent deal was a Merger/Acquisition with Compusult. The deal was made on 01-Apr-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Compusult | 01-Apr-2025 | Merger/Acquisition | IT Consulting and Outsourcing | ||
| Karaka Meadows (105 Hectare Site in Auckland, New Zealand) | 26-Apr-2023 | Corporate Asset Purchase | Buildings and Property |
Fisher & Paykel Healthcare ESG
Risk Overview
Risk Rating
Updated November, 17, 2026
20.57 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Fisher & Paykel Healthcare Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Compusult | Mount Pearl, Canada | 1985 |
Fisher & Paykel Healthcare FAQs
-
When was Fisher & Paykel Healthcare founded?
Fisher & Paykel Healthcare was founded in 1969.
-
Where is Fisher & Paykel Healthcare headquartered?
Fisher & Paykel Healthcare is headquartered in Auckland, New Zealand.
-
What is the size of Fisher & Paykel Healthcare?
Fisher & Paykel Healthcare has 7,375 total employees.
-
What industry is Fisher & Paykel Healthcare in?
Fisher & Paykel Healthcare’s primary industry is Therapeutic Devices.
-
Is Fisher & Paykel Healthcare a private or public company?
Fisher & Paykel Healthcare is a Public company.
-
What is Fisher & Paykel Healthcare’s stock symbol?
The ticker symbol for Fisher & Paykel Healthcare is FPH.
-
What is the current stock price of Fisher & Paykel Healthcare?
As of 17-Nov-2026 the stock price of Fisher & Paykel Healthcare is $26.67.
-
What is the current market cap of Fisher & Paykel Healthcare?
The current market capitalization of Fisher & Paykel Healthcare is $15.7B.
-
What is Fisher & Paykel Healthcare’s current revenue?
The trailing twelve month revenue for Fisher & Paykel Healthcare is $1.35B.
-
Who are Fisher & Paykel Healthcare’s competitors?
LivaNova, Inspire Medical Systems, Ottobock, Wellell, and Inogen are some of the 32 competitors of Fisher & Paykel Healthcare.
-
What is Fisher & Paykel Healthcare’s annual earnings per share (EPS)?
Fisher & Paykel Healthcare’s EPS for 12 months was $0.47.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process